Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commentary: New sight, lost sight, insight, and novel sight.

JTCVS open·2022
Same author

Commentary: A phase in the haze surrounding the maze.

JTCVS techniques·2021
Same author

Tips for authors of surgical manuscripts from senior reviewers.

Surgery·2021
Same author

Commentary: POAF goes POOF!

The Journal of thoracic and cardiovascular surgery·2020
Same author

Editors' introduction to: Toward a unified theory of occurrence and recurrence of hiatal hernia.

Surgery·2020
Same author

Commentary on: Prevalence and extent of industry support for program directors of surgical fellowships in the United States.

Surgery·2020

Related Experiment Videos

Statins for surgical patients.

Trevor M Williams1, Alden H Harken

  • 1Department of Surgery, University of California, San Francisco-East Bay, Oakland, CA, USA. trevor.williams@mail.mcgill.ca

Annals of Surgery
|December 25, 2007
PubMed
Summary

Perioperative statin treatment shows benefits for reducing surgical complications. Evidence suggests statins should be continued in surgical patients due to their protective effects and to avoid a rebound effect.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Surgical Risk Management

Background:

  • Vascular, cerebrovascular, and cardiovascular complications frequently occur in surgical patients.
  • While beta-blockers are established for perioperative cardiac risk reduction, statins offer a strong pathophysiologic basis for prophylaxis.

Purpose of the Study:

  • To evaluate perioperative statin treatment efficacy.
  • To explore the pleiotropic effects of statins in surgical contexts.
  • To propose a rational strategy for perioperative risk reduction using statins.

Main Methods:

  • Conducted a PubMed search using "surgery" and "hydroxymethylglutaryl-CoA reductase inhibitors" (statins).
  • Included studies on statin treatment outcomes in surgical series, excluding transplant surgery and studies without relevant outcomes.

Related Experiment Videos

  • Reviewed medical literature on statin use and cardiac outcomes, incorporating basic science investigations on mechanisms of perioperative risk reduction.
  • Main Results:

    • Delineated the pharmacology and pleiotropic effects of statins.
    • Identified multiple beneficial outcomes associated with perioperative statin use.
    • Observed apparent benefits of perioperative statins, though clinical recommendations are limited by the availability of only one clinical trial.

    Conclusions:

    • Evidence supports a rebound effect upon statin discontinuation.
    • Statin treatment should be initiated and maintained in surgical patients.
    • Current literature indicates statins provide preoperative protection.